SYNGENX

The mark SYNGENX covers medical apparatus and instruments for medical, clinical, diagnostic and therapeutic uses, specifically apparatus for purifying certain cell populations in blood, bone marrow or adipose tissue (Class 10). The application was filed by SynGen Inc. (original registrant and owner at publication) and a later entry identifies THERMOGENESIS CORP. as a subsequent owner after registration; the mark issued as U.S. Reg. No. 4448528. Registration was cancelled on July 17, 2020 because the registrant did not file an acceptable declaration under Section 8. Recent Activity The application was filed April 27, 2012, published for opposition September 4, 2012, and registered December 10, 2013 with a first use in commerce dated June 30, 2013. Assignment records include multiple security-interest filings and an assignment recorded August 30, 2017 conveying the entire interest to Thermogenesis Corp.